101 related articles for article (PubMed ID: 19621898)
21. Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity.
Paula-Lima AC; Tricerri MA; Brito-Moreira J; Bomfim TR; Oliveira FF; Magdesian MH; Grinberg LT; Panizzutti R; Ferreira ST
Int J Biochem Cell Biol; 2009 Jun; 41(6):1361-70. PubMed ID: 19130896
[TBL] [Abstract][Full Text] [Related]
22. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
23. Zinc binding to Alzheimer's Abeta(1-16) peptide results in stable soluble complex.
Kozin SA; Zirah S; Rebuffat S; Hoa GH; Debey P
Biochem Biophys Res Commun; 2001 Jul; 285(4):959-64. PubMed ID: 11467845
[TBL] [Abstract][Full Text] [Related]
24. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
25. A new series of 1,3-dihidro-imidazo[1,5-c]thiazole-5,7-dione derivatives: synthesis and interaction with Abeta(25-35) amyloid peptide.
Campiglia P; Scrima M; Grimaldi M; Cioffi G; Bertamino A; Sala M; Aquino C; Gomez-Monterrey I; Grieco P; Novellino E; D'Ursi AM
Chem Biol Drug Des; 2009 Sep; 74(3):224-33. PubMed ID: 19703024
[TBL] [Abstract][Full Text] [Related]
26. Destabilizing Alzheimer's Abeta(42) protofibrils with morin: mechanistic insights from molecular dynamics simulations.
Lemkul JA; Bevan DR
Biochemistry; 2010 May; 49(18):3935-46. PubMed ID: 20369844
[TBL] [Abstract][Full Text] [Related]
27. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
28. Zinc-amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species.
Noy D; Solomonov I; Sinkevich O; Arad T; Kjaer K; Sagi I
J Am Chem Soc; 2008 Jan; 130(4):1376-83. PubMed ID: 18179213
[TBL] [Abstract][Full Text] [Related]
29. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.
Han D; Wang H; Yang P
Biometals; 2008 Apr; 21(2):189-96. PubMed ID: 17629774
[TBL] [Abstract][Full Text] [Related]
30. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
31. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
Benseny-Cases N; Cócera M; Cladera J
Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
[TBL] [Abstract][Full Text] [Related]
32. Proteolytic antibody light chains alter beta-amyloid aggregation and prevent cytotoxicity.
Liu R; McAllister C; Lyubchenko Y; Sierks MR
Biochemistry; 2004 Aug; 43(31):9999-10007. PubMed ID: 15287727
[TBL] [Abstract][Full Text] [Related]
33. Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay.
Klunk WE; Jacob RF; Mason RP
Anal Biochem; 1999 Jan; 266(1):66-76. PubMed ID: 9887214
[TBL] [Abstract][Full Text] [Related]
34. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation.
Bieschke J; Zhang Q; Powers ET; Lerner RA; Kelly JW
Biochemistry; 2005 Apr; 44(13):4977-83. PubMed ID: 15794636
[TBL] [Abstract][Full Text] [Related]
35. Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Cherny RA; Barnham KJ; Lynch T; Volitakis I; Li QX; McLean CA; Multhaup G; Beyreuther K; Tanzi RE; Masters CL; Bush AI
J Struct Biol; 2000 Jun; 130(2-3):209-16. PubMed ID: 10940226
[TBL] [Abstract][Full Text] [Related]
36. Influence of multiple metal ions on beta-amyloid aggregation and dissociation on a solid surface.
Ryu J; Girigoswami K; Ha C; Ku SH; Park CB
Biochemistry; 2008 May; 47(19):5328-35. PubMed ID: 18422346
[TBL] [Abstract][Full Text] [Related]
37. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
[TBL] [Abstract][Full Text] [Related]
39. The effect of Abeta conformation on the metal affinity and aggregation mechanism studied by circular dichroism spectroscopy.
Chen YR; Huang HB; Chyan CL; Shiao MS; Lin TH; Chen YC
J Biochem; 2006 Apr; 139(4):733-40. PubMed ID: 16672274
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence anisotropy: a method for early detection of Alzheimer beta-peptide (Abeta) aggregation.
Allsop D; Swanson L; Moore S; Davies Y; York A; El-Agnaf OM; Soutar I
Biochem Biophys Res Commun; 2001 Jul; 285(1):58-63. PubMed ID: 11437372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
